MediciNova Inc (NASDAQ:MNOV)

2.90
Data as of Dec 26
 -0.14 / -4.61%
Today’s Change
1.66
Today|||52-Week Range
5.25
+35.51%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$73.6M

Company Description

MediciNova, Inc. operates as a development stage biopharmaceutical company with interest in acquiring and developing novel, small molecule therapeutics for the treatment of serious diseases for the treatment of diseases with unmet medical need with a specific focus on the U.S. market. The company's development pipeline consists of six product development programs which have been in clinical development for the treatment of acute exacerbations of asthma, chronic obstructive pulmonary disease exacerbations, multiple sclerosis and other neurologic conditions, asthma, interstitial cystitis, solid tumor cancers, generalized anxiety disorder, preterm labor and urinary incontinence and two preclinical-stage compounds for the treatment of thrombotic disorders. MediciNova was founded by Yuichi Iwaki on September 26, 2000 and is headquartered in San Diego, CA.

Contact Information

MediciNova, Inc.
4350 La Jolla Village Drive
San Diego California 92122
P:(858) 373-1500
Investor Relations:
(858) 373-1300

Employees

Shareholders

Mutual fund holders3.27%
Individual stakeholders15.35%
Other institutional1.73%

Top Executives

Yuichi IwakiPresident, Chief Executive Officer & Director
Esther van den BoomChief Financial & Accounting Officer
Kazuko MatsudaChief Medical Officer
Masatsune OkajimaVice President & Head-Japanese Office
Geoffrey G. O'BrienVice President

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.